P
Paulus Kirchhof
Researcher at University of Birmingham
Publications - 659
Citations - 119822
Paulus Kirchhof is an academic researcher from University of Birmingham. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 100, co-authored 558 publications receiving 106459 citations. Previous affiliations of Paulus Kirchhof include United States Department of Veterans Affairs & Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
‘European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)’ The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). [Eur Heart J 2012;33:1635–1701, doi: 10.1093/eurheartj/ehs092]
J. Perk,G. De Backer,H. Gohlke,I. Graham,Zeljko Reiner,W.M.M. Verschuren,C. Albus,P. Benlian,G. Boysen,Renata Cifkova,Christi Deaton,S. Ebrahim,M. Fisher,G. Germano,R. Hobbs,Arno W. Hoes,S. Karadeniz,A. Mezzani,E. Prescott,Lars Rydén,M. Scherer,M. Syvänne,W.J.M. Scholte op Reimer,C. Vrints,D. Wood,José Luis Zamorano,F. Zannad,M.T. Cooney,Jeroen J. Bax,Helmut Baumgartner,Claudio Ceconi,Veronica Dean,Robert Fagard,Christian Funck-Brentano,D. Hasdai,Paulus Kirchhof,Juhani Knuuti,Philippe Kolh,T. McDonagh,C. Moulin,Bogdan A. Popescu,Ž. Reiner,Udo Sechtem,Per Anton Sirnes,Michal Tendera,Adam Torbicki,Alec Vahanian,Stephan Windecker,Victor Aboyans,E.A. Ezquerra,C. Baigent,C. Brotons,G. Burell,A. Ceriello,J. De Sutter,J. Deckers,S. Del Prato,H.C. Diener,Donna Fitzsimons,Z. Fras,R. Hambrecht,P. Jankowski,U. Keil,M. Kirby,M.L. Larsen,Giuseppe Mancia,A.J. Manolis,J. McMurray,A. Pająk,A. Parkhomenko,L. Rallidis,F. Rigo,E. Rocha,L.M. Ruilope,E. A. van der Velde,D. Vanuzzo,Margus Viigimaa,M. Volpe,O. Wiklund,C. Wolpert +79 more
Journal ArticleDOI
XANTUS : a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
A. John Camm,Pierre Amarenco,Sylvia Haas,Susanne Hess,Paulus Kirchhof,Paulus Kirchhof,Silvia Kuhls,Martin van Eickels,Alexander G.G. Turpie +8 more
TL;DR: Rates of stroke and major bleeding were low in patients receiving rivaroxaban in routine clinical practice in the NVAF patient population.
Journal ArticleDOI
Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice
Paulus Kirchhof,Larissa Fabritz,Melanie Zwiener,Henning Witt,Michael Schäfers,Stephan Zellerhoff,Matthias Paul,Timur Athai,Karl-Heinz Hiller,Hideo Baba,Günter Breithardt,Patricia Ruiz,Thomas Wichter,Bodo Levkau +13 more
TL;DR: A functional role for plakoglobin and training in the development of ARVC is suggested, as Manifestation of the phenotype is accelerated by endurance training.
Journal ArticleDOI
Outcome parameters for trials in atrial fibrillation: executive summary.
Paulus Kirchhof,Angelo Auricchio,Jeroen J. Bax,Harry J.G.M. Crijns,John Camm,Hans-Christoph Diener,Andreas Goette,Gerd Hindricks,Stefan H. Hohnloser,Lukas Kappenberger,Karl Heinz Kuck,Gregory Y.H. Lip,Bertil Olsson,Thomas Meinertz,Silvia G. Priori,Ursula Ravens,Gerhard Steinbeck,Elisabeth Svernhage,Jan Tijssen,Alphons Vincent,Günter Breithardt +20 more
TL;DR: An expert consensus of required outcome parameters in seven relevant outcome domains, namely death, stroke, symptoms and quality of life, rhythm, left ventricular function, cost, and emerging outcome parameters, are described.
Journal ArticleDOI
EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation : executive summary
Hein Heidbuchel,Peter Verhamme,Marco Alings,Matthias Antz,Werner Hacke,Jonas Oldgren,Peter Sinnaeve,A. John Camm,Paulus Kirchhof,Paulus Kirchhof +9 more
TL;DR: This text is an executive summary of a practical guide that the European Heart Rhythm Association has assembled to help physicians in the use of the different NOACs to prevent stroke in patients with non-valvular atrial fibrillation.